Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States

Oluwatoyin M. Adeyemi, Denis Agniel, Audrey L. French, Phyllis C. Tien, Kathleen Weber, Marshall J. Glesby, Maria C. Villacres, Anjali Sharma, Daniel Merenstein, Elizabeth T. Golub, William Meyer, Mardge Cohen

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Background: Vitamin D deficiency is of increasing concern in HIV-infected persons because of its reported association with a number of negative health outcomes that are common in HIV. We undertook this study to determine the prevalence and predictors of vitamin D deficiency among a nationally representative cohort of middle-aged, ethnically diverse, HIV-infected and HIV-uninfected women enrolled in the Women's Interagency HIV Study (WIHS). Methods: Vitamin D testing was performed by Quest Diagnostics on frozen sera using the liquid chromatography/mass spectroscopy method. Vitamin D deficiency was defined as 25(OH)D ≤20 ng/mL. Comparisons of continuous and categorical characteristics among HIV-infected and HIV-uninfected women were made by Wilcoxon tests and Pearson χ tests, respectively. Results: One thousand seven hundred seventy-eight women (1268 HIV positive) were studied. Sixty-three percent had vitamin D deficiency (60% HIV positive vs. 72% HIV negative; P < 0.001). Multivariable predictors of vitamin D deficiency were being African American (adjusted odds ratio 3.02), Hispanic (adjusted odds ratio 1.40), body mass index (adjusted odds ratio 1.43), age (adjusted odds ratio 0.84), HIV positive (adjusted odds ratio 0.76), glomerular filtration rate <90•mL•min (adjusted odds ratio 0.94), and WIHS sites Los Angeles (adjusted odds ratio 0.66) and Chicago (adjusted odds ratio 0.63). In the HIV-positive women, multivariate predictors were undetectable HIV RNA (adjusted odds ratio 0.69), CD4 50-200 cells per cubic millimeter (adjusted odds ratio 1.60), CD4 <50 cells per cubic millimeter (adjusted odds ratio 1.94), and recent protease inhibitor use (adjusted odds ratio 0.67). Conclusions: In this study of more than 1700 women in the United States, most women with or without HIV infection had low vitamin D levels and African American women had the highest rates of vitamin D deficiency. An understanding of the role that vitamin D deficiency plays in non-AIDS-related morbidities is planned for investigation in WIHS.

Original languageEnglish (US)
Pages (from-to)197-204
Number of pages8
JournalJournal of Acquired Immune Deficiency Syndromes
Volume57
Issue number3
DOIs
StatePublished - Jul 1 2011
Externally publishedYes

Fingerprint

Vitamin D Deficiency
HIV
Odds Ratio
Vitamin D
African Americans
Los Angeles
Protease Inhibitors
Glomerular Filtration Rate
Hispanic Americans
Liquid Chromatography
HIV Infections

Keywords

  • HIV infected
  • HIV uninfected
  • vitamin D
  • vitamin D deficiency

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Adeyemi, O. M., Agniel, D., French, A. L., Tien, P. C., Weber, K., Glesby, M. J., ... Cohen, M. (2011). Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. Journal of Acquired Immune Deficiency Syndromes, 57(3), 197-204. https://doi.org/10.1097/QAI.0b013e31821ae418

Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. / Adeyemi, Oluwatoyin M.; Agniel, Denis; French, Audrey L.; Tien, Phyllis C.; Weber, Kathleen; Glesby, Marshall J.; Villacres, Maria C.; Sharma, Anjali; Merenstein, Daniel; Golub, Elizabeth T.; Meyer, William; Cohen, Mardge.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 57, No. 3, 01.07.2011, p. 197-204.

Research output: Contribution to journalArticle

Adeyemi, OM, Agniel, D, French, AL, Tien, PC, Weber, K, Glesby, MJ, Villacres, MC, Sharma, A, Merenstein, D, Golub, ET, Meyer, W & Cohen, M 2011, 'Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States', Journal of Acquired Immune Deficiency Syndromes, vol. 57, no. 3, pp. 197-204. https://doi.org/10.1097/QAI.0b013e31821ae418
Adeyemi, Oluwatoyin M. ; Agniel, Denis ; French, Audrey L. ; Tien, Phyllis C. ; Weber, Kathleen ; Glesby, Marshall J. ; Villacres, Maria C. ; Sharma, Anjali ; Merenstein, Daniel ; Golub, Elizabeth T. ; Meyer, William ; Cohen, Mardge. / Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. In: Journal of Acquired Immune Deficiency Syndromes. 2011 ; Vol. 57, No. 3. pp. 197-204.
@article{fd3fb4c24e21481f9e2568e44ffa4712,
title = "Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States",
abstract = "Background: Vitamin D deficiency is of increasing concern in HIV-infected persons because of its reported association with a number of negative health outcomes that are common in HIV. We undertook this study to determine the prevalence and predictors of vitamin D deficiency among a nationally representative cohort of middle-aged, ethnically diverse, HIV-infected and HIV-uninfected women enrolled in the Women's Interagency HIV Study (WIHS). Methods: Vitamin D testing was performed by Quest Diagnostics on frozen sera using the liquid chromatography/mass spectroscopy method. Vitamin D deficiency was defined as 25(OH)D ≤20 ng/mL. Comparisons of continuous and categorical characteristics among HIV-infected and HIV-uninfected women were made by Wilcoxon tests and Pearson χ tests, respectively. Results: One thousand seven hundred seventy-eight women (1268 HIV positive) were studied. Sixty-three percent had vitamin D deficiency (60{\%} HIV positive vs. 72{\%} HIV negative; P < 0.001). Multivariable predictors of vitamin D deficiency were being African American (adjusted odds ratio 3.02), Hispanic (adjusted odds ratio 1.40), body mass index (adjusted odds ratio 1.43), age (adjusted odds ratio 0.84), HIV positive (adjusted odds ratio 0.76), glomerular filtration rate <90•mL•min (adjusted odds ratio 0.94), and WIHS sites Los Angeles (adjusted odds ratio 0.66) and Chicago (adjusted odds ratio 0.63). In the HIV-positive women, multivariate predictors were undetectable HIV RNA (adjusted odds ratio 0.69), CD4 50-200 cells per cubic millimeter (adjusted odds ratio 1.60), CD4 <50 cells per cubic millimeter (adjusted odds ratio 1.94), and recent protease inhibitor use (adjusted odds ratio 0.67). Conclusions: In this study of more than 1700 women in the United States, most women with or without HIV infection had low vitamin D levels and African American women had the highest rates of vitamin D deficiency. An understanding of the role that vitamin D deficiency plays in non-AIDS-related morbidities is planned for investigation in WIHS.",
keywords = "HIV infected, HIV uninfected, vitamin D, vitamin D deficiency",
author = "Adeyemi, {Oluwatoyin M.} and Denis Agniel and French, {Audrey L.} and Tien, {Phyllis C.} and Kathleen Weber and Glesby, {Marshall J.} and Villacres, {Maria C.} and Anjali Sharma and Daniel Merenstein and Golub, {Elizabeth T.} and William Meyer and Mardge Cohen",
year = "2011",
month = "7",
day = "1",
doi = "10.1097/QAI.0b013e31821ae418",
language = "English (US)",
volume = "57",
pages = "197--204",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States

AU - Adeyemi, Oluwatoyin M.

AU - Agniel, Denis

AU - French, Audrey L.

AU - Tien, Phyllis C.

AU - Weber, Kathleen

AU - Glesby, Marshall J.

AU - Villacres, Maria C.

AU - Sharma, Anjali

AU - Merenstein, Daniel

AU - Golub, Elizabeth T.

AU - Meyer, William

AU - Cohen, Mardge

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Background: Vitamin D deficiency is of increasing concern in HIV-infected persons because of its reported association with a number of negative health outcomes that are common in HIV. We undertook this study to determine the prevalence and predictors of vitamin D deficiency among a nationally representative cohort of middle-aged, ethnically diverse, HIV-infected and HIV-uninfected women enrolled in the Women's Interagency HIV Study (WIHS). Methods: Vitamin D testing was performed by Quest Diagnostics on frozen sera using the liquid chromatography/mass spectroscopy method. Vitamin D deficiency was defined as 25(OH)D ≤20 ng/mL. Comparisons of continuous and categorical characteristics among HIV-infected and HIV-uninfected women were made by Wilcoxon tests and Pearson χ tests, respectively. Results: One thousand seven hundred seventy-eight women (1268 HIV positive) were studied. Sixty-three percent had vitamin D deficiency (60% HIV positive vs. 72% HIV negative; P < 0.001). Multivariable predictors of vitamin D deficiency were being African American (adjusted odds ratio 3.02), Hispanic (adjusted odds ratio 1.40), body mass index (adjusted odds ratio 1.43), age (adjusted odds ratio 0.84), HIV positive (adjusted odds ratio 0.76), glomerular filtration rate <90•mL•min (adjusted odds ratio 0.94), and WIHS sites Los Angeles (adjusted odds ratio 0.66) and Chicago (adjusted odds ratio 0.63). In the HIV-positive women, multivariate predictors were undetectable HIV RNA (adjusted odds ratio 0.69), CD4 50-200 cells per cubic millimeter (adjusted odds ratio 1.60), CD4 <50 cells per cubic millimeter (adjusted odds ratio 1.94), and recent protease inhibitor use (adjusted odds ratio 0.67). Conclusions: In this study of more than 1700 women in the United States, most women with or without HIV infection had low vitamin D levels and African American women had the highest rates of vitamin D deficiency. An understanding of the role that vitamin D deficiency plays in non-AIDS-related morbidities is planned for investigation in WIHS.

AB - Background: Vitamin D deficiency is of increasing concern in HIV-infected persons because of its reported association with a number of negative health outcomes that are common in HIV. We undertook this study to determine the prevalence and predictors of vitamin D deficiency among a nationally representative cohort of middle-aged, ethnically diverse, HIV-infected and HIV-uninfected women enrolled in the Women's Interagency HIV Study (WIHS). Methods: Vitamin D testing was performed by Quest Diagnostics on frozen sera using the liquid chromatography/mass spectroscopy method. Vitamin D deficiency was defined as 25(OH)D ≤20 ng/mL. Comparisons of continuous and categorical characteristics among HIV-infected and HIV-uninfected women were made by Wilcoxon tests and Pearson χ tests, respectively. Results: One thousand seven hundred seventy-eight women (1268 HIV positive) were studied. Sixty-three percent had vitamin D deficiency (60% HIV positive vs. 72% HIV negative; P < 0.001). Multivariable predictors of vitamin D deficiency were being African American (adjusted odds ratio 3.02), Hispanic (adjusted odds ratio 1.40), body mass index (adjusted odds ratio 1.43), age (adjusted odds ratio 0.84), HIV positive (adjusted odds ratio 0.76), glomerular filtration rate <90•mL•min (adjusted odds ratio 0.94), and WIHS sites Los Angeles (adjusted odds ratio 0.66) and Chicago (adjusted odds ratio 0.63). In the HIV-positive women, multivariate predictors were undetectable HIV RNA (adjusted odds ratio 0.69), CD4 50-200 cells per cubic millimeter (adjusted odds ratio 1.60), CD4 <50 cells per cubic millimeter (adjusted odds ratio 1.94), and recent protease inhibitor use (adjusted odds ratio 0.67). Conclusions: In this study of more than 1700 women in the United States, most women with or without HIV infection had low vitamin D levels and African American women had the highest rates of vitamin D deficiency. An understanding of the role that vitamin D deficiency plays in non-AIDS-related morbidities is planned for investigation in WIHS.

KW - HIV infected

KW - HIV uninfected

KW - vitamin D

KW - vitamin D deficiency

UR - http://www.scopus.com/inward/record.url?scp=79959763397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959763397&partnerID=8YFLogxK

U2 - 10.1097/QAI.0b013e31821ae418

DO - 10.1097/QAI.0b013e31821ae418

M3 - Article

VL - 57

SP - 197

EP - 204

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 3

ER -